Voyager Therapeutics, Inc. (VYGR)
Market: NASD |
Currency: USD
Address: 75 Hayden Avenue
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Show more
📈 Voyager Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$15.78
-
Upside/Downside from Analyst Target:
419.01%
-
Broker Call:
23
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Voyager Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2026-05-04 (estimated upcoming) | - |
| 2026-03-09 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-09 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-08-03 (estimated upcoming) | - |
| 2025-05-11 | - |
| 2025-05-06 | -0.53 |
| 2025-03-11 | -0.59 |
| 2025-02-25 | - |
| 2024-11-12 | -0.16 |
| 2024-08-06 | -0.18 |
| 2024-08-05 | -0.18 |
| 2024-05-13 | -0.2 |
| 2024-05-12 | -0.2 |
| 2024-02-28 | 1.25 |
| 2024-02-27 | 1.25 |
| 2023-11-06 | -0.59 |
| 2023-11-05 | -0.59 |
| 2023-08-03 | -0.51 |
| 2023-08-02 | -0.51 |
| 2023-05-09 | 2.94 |
| 2023-05-08 | 2.94 |
| 2023-03-07 | -0.61 |
| 2023-03-06 | -0.61 |
| 2022-11-08 | 0.45 |
| 2022-11-07 | 0.45 |
| 2022-08-04 | -0.5 |
| 2022-08-03 | -0.5 |
| 2022-05-04 | -0.56 |
| 2022-05-03 | -0.56 |
| 2022-03-08 | 0.15 |
| 2022-03-07 | 0.15 |
| 2021-11-02 | -0.67 |
| 2021-11-01 | -0.67 |
| 2021-08-09 | -0.8 |
| 2021-08-08 | -0.8 |
| 2021-05-10 | -0.58 |
| 2021-05-09 | -0.58 |
| 2021-02-25 | -0.43 |
| 2021-02-24 | -0.43 |
| 2020-11-09 | 2.27 |
| 2020-11-08 | 2.27 |
| 2020-08-10 | -0.23 |
| 2020-08-09 | -0.23 |
| 2020-05-05 | -0.66 |
| 2020-03-02 | -0.34 |
| 2019-11-05 | -0.41 |
| 2019-08-08 | 0.29 |
| 2019-05-06 | -0.81 |
| 2019-02-25 | -0.7 |
| 2018-11-06 | -0.63 |
| 2018-08-06 | -0.8 |
| 2018-05-09 | -0.63 |
| 2018-03-13 | -0.4 |
| 2017-11-01 | -0.89 |
| 2017-08-07 | -0.73 |
| 2017-05-08 | -0.65 |
| 2017-03-14 | -0.57 |
| 2016-11-09 | -0.35 |
| 2016-08-10 | -0.37 |
| 2016-05-11 | -0.29 |
| 2016-03-16 | -0.67 |
| 2015-12-16 | -5.25 |
| 2015-11-15 | - |
📰 Related News & Research
No related articles found for "voyager therapeutics".
